The Myc family of oncoproteins (c-, N-, and L-Myc) have been implicated in a wide range of cellular behavior including cell cycle entry and maintenance, differentiation, and apoptosis. In addition rearrangements at myc gene loci have been associated with many types of neoplasia in numerous species, including humans. Despite a vast amount of information on the properties and biological effects of Myc we lack a direct molecular link between these cellular processes and the Myc oncoprotein itself. Recently Max, a specific Myc dimerization partner, has been identified which forms a sequence-specific DNA binding complex with Myc. The Myc:Max complex appears to function as a transcriptional activator and evidence suggests that the relative abundances of constitutively expressed Max protein and highly regulated Myc protein may serve to determine the activity of this transcriptional 'switch'. In this application we propose to extend our studies on Myc and Max and to examine in detail the biochemical and biological properties of a new Max binding protein, Mad. Mad competes with Myc for binding to Max and appears to act as a repressor which can antagonize Myc's transcriptional activation function. This suggests that Myc, Max, and Mad may form a small network of interacting proteins. To explore the dynamics of this network we plan to characterize the properties and interactions of Mad in vivo and determine whether it may negatively influence Myc's transforming activity and act as a tumor suppressor gene. We will also probe the effects of both Max and Mad expression on the G0/G1 transition, cell proliferation, differentiation, and apoptosis. Biological roles for Mad in development will be studied by means of targeted gene disruptions in mice. Another series of experiments will examine the transcriptional properties of myc, Mad, and Max by analyzing, through site specific mutagenesis, the domains of these proteins that contribute to transcription activation and repression. The effects of alternative binding sites and promoter structure will also be analyzed. An in vitro transcription system will be developed to study the biochemical properties of these proteins in greater detail and the effects of other transcription factors on their activities. Finally we will attempt to extend our knowledge of the network of protein interactions involved in Myc function by using interaction cloning strategies to identify new binding partners for Myc, Max and Mad. The information gained from the studies proposed here should enable us to understand both how Myc functions at the molecular level and the manner in which this function is regulated.
| Schaub, Franz X; Dhankani, Varsha; Berger, Ashton C et al. (2018) Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas. Cell Syst 6:282-300.e2 |
| Poudel, Kumud R; Roh-Johnson, Minna; Su, Allen et al. (2018) Competition between TIAM1 and Membranes Balances Endophilin A3 Activity in Cancer Metastasis. Dev Cell 45:738-752.e6 |
| Gu, Haiwei; Carroll, Patrick A; Du, Jianhai et al. (2016) Quantitative Method to Investigate the Balance between Metabolism and Proteome Biomass: Starting from Glycine. Angew Chem Int Ed Engl 55:15646-15650 |
| Kanatsu-Shinohara, Mito; Tanaka, Takashi; Ogonuki, Narumi et al. (2016) Myc/Mycn-mediated glycolysis enhances mouse spermatogonial stem cell self-renewal. Genes Dev 30:2637-2648 |
| Scognamiglio, Roberta; Cabezas-Wallscheid, Nina; Thier, Marc Christian et al. (2016) Myc Depletion Induces a Pluripotent Dormant State Mimicking Diapause. Cell 164:668-80 |
| Sanchez, Erica L; Carroll, Patrick A; Thalhofer, Angel B et al. (2015) Latent KSHV Infected Endothelial Cells Are Glutamine Addicted and Require Glutaminolysis for Survival. PLoS Pathog 11:e1005052 |
| Gu, Haiwei; Du, Jianhai; Carnevale Neto, Fausto et al. (2015) Metabolomics method to comprehensively analyze amino acids in different domains. Analyst 140:2726-34 |
| Diolaiti, Daniel; McFerrin, Lisa; Carroll, Patrick A et al. (2015) Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis. Biochim Biophys Acta 1849:484-500 |
| Carroll, Patrick A; Eisenman, Robert N (2015) Growing old with Myc. Cell 160:365-6 |
| Carroll, Patrick A; Diolaiti, Daniel; McFerrin, Lisa et al. (2015) Deregulated Myc requires MondoA/Mlx for metabolic reprogramming and tumorigenesis. Cancer Cell 27:271-85 |
Showing the most recent 10 out of 49 publications
